Past Issues

2021: Volume 2, Issue 1

Medication Assisted Treatment Protocol

David Michael Mathis

11035 Lavender Hill Dr. STE. 160

Corresponding author: David Michael Mathis, 11035 Lavender Hill Dr. STE. 160, E-mail: [email protected]

Received Date: April 17, 2021

Publication Date: May 31, 2021


This article describes a protocol to be able to utilize medication assisted treatment options for patients dependent on opioids. The first step is using a 15-day Klonopin taper for effect detox of acute opioid withdrawal. Once detoxed, the patient can be started on low dose methadone or low dose Buprenorphine. Titration above 40 mg of Methadone, or 8 mg of buprenorphine will usually not be needed. Buprenorphine is utilized as the mono product, Subutex. Avoiding Suboxone eliminates the risk of reemergence of acute opioid withdrawal symptoms.

A description of how to transition to Naltrexone is provided. There are some differences between Methadone and Buprenorphine in the transition to Naltrexone. Once the patient is transitioned to Naltrexone, the stage is set for the patient to be able to get off medication assisted treatment.

KEYWORDS: Naltrexone; Buprenorphine; Protocol; Medication; Treatment

Suggested For You
Creative Commons License

Open Access by Magnus Med Club Ltd is licensed under a Creative Commons Attribution 4.0 International License. Based On a Work at

©2018 Magnus Med Club Ltd. All rights Reserved. Traditional Medicine is an Independent Peer-Reviewed Traditional Medicine Journal. Terms of ServicePrivacy Policy